These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30358722)

  • 1. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys.
    Adams MR; Williams JK; Clarkson TB; Jayo MJ
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):915-34. PubMed ID: 1822826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
    Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN
    Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis.
    Meyer MR; Haas E; Barton M
    Gend Med; 2008; 5 Suppl A():S19-33. PubMed ID: 18395680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
    N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB; Mehaffey MH
    Am J Primatol; 2009 Sep; 71(9):785-93. PubMed ID: 19382155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F; Kalelioglu I; Turfanda A
    Angiology; 2009; 60(3):308-17. PubMed ID: 18505742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women.
    Christian RC; Harrington S; Edwards WD; Oberg AL; Fitzpatrick LA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1062-7. PubMed ID: 11889163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and atherosclerosis: modulation by oestrogen.
    Barton M
    Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F; Trémollières F; Gourdy P; Arnal JF
    Maturitas; 2011 Feb; 68(2):165-73. PubMed ID: 21167666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD; Kaplan JR; Burkman RT
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):475-93. PubMed ID: 12353669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies about HRT--lessons from monkey models.
    Clarkson TB; Appt SE
    Maturitas; 2005 May; 51(1):64-74. PubMed ID: 15883111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
    Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW
    Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of soy supplementation on postmenopausal atherosclerosis are dependent on pretreatment stage of plaque progression.
    Meléndez GC; Register TC; Appt SE; Clarkson TB; Franke AA; Kaplan JR
    Menopause; 2015 Mar; 22(3):289-96. PubMed ID: 25072952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.
    Appt SE; Clarkson TB; Lees CJ; Anthony MS
    Maturitas; 2006 Sep; 55(2):187-94. PubMed ID: 16574351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.